4
Changes in Ownership
Editas Medicine, Inc. Filed Acc 0001179110-18-010732
Chief Technology Officer sold 7,000 shares at an average $29.78 ($208,430)
- Chief Technology Officer acquired 7,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myer Vickesh Chief Technology Officer | 2018-08-17 | Option exercise | +3,000 | $0.65 | $1,950 | 3,000 | D |
| Myer Vickesh Chief Technology Officer | 2018-08-17 | Sale | −3,000 | $29.65 | $88,950 | 0 | D |
| Myer Vickesh Chief Technology Officer | 2018-08-20 | Option exercise | +3,600 | $11.21 | $40,356 | 3,600 | D |
| Myer Vickesh Chief Technology Officer | 2018-08-20 | Sale | −3,600 | $29.81 | $107,316 | 0 | D |
| Myer Vickesh Chief Technology Officer | 2018-08-20 | Option exercise | +400 | $11.21 | $4,484 | 400 | D |
| Myer Vickesh Chief Technology Officer | 2018-08-20 | Sale | −400 | $30.41 | $12,164 | 0 | D |
| Derivatives | |||||||
| Myer Vickesh Chief Technology Officer | 2018-08-17 | Option exercise · Stock Option (right to buy) | −3,000 | 94,307 | D | ||
| Myer Vickesh Chief Technology Officer | 2018-08-20 | Option exercise · Stock Option (right to buy) | −4,000 | 72,897 | D | ||
| Open-market sales · 7,000 sh · avg $29.78 · $208,430 | |||||||
Loading xslF345X03/edgar.xml…